Medium urgency

US-CONGRESS HR9396: Prior Authorization Accountability Act

Detected August 21, 2026 · in Pharmacy & Controlled Substances

The Prior Authorization Accountability Act aims to enhance transparency and accountability in the prior authorization process for prescription drugs, impacting pharmacies and healthcare providers.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 21, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the current text.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

New requirements for transparency and accountability in the prior authorization process for controlled substances.

Who it affects

Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies.

What you must do

Prepare to comply with new transparency measures regarding prior authorizations for prescriptions.

Deadline

Not specified in the current text.

Source: https://www.congress.gov/bill/119th-congress/house-bill/9396

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances